Zentalis Pharmaceuticals

-$1.50 (-5.66%) As of 1:51 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.

About ZNTL

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations.

CEO
Kimberly L. Blackwell
Employees
177
Headquarters
New York, New York
Founded
2014

ZNTL Key Statistics

Market cap
1.40B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.33M
High today
$25.85
Low today
$24.87
Open price
$25.22
Volume
65.84K
52 Week high
$87.19
52 Week low
$17.33

ZNTL Earnings

-$1.48
-$0.99
-$0.49
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$1.21 per share
Actual
-$1.31 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure